InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Hopkinson Craig C., Dirigeant. Officer active across 1 companies, notably Alkermes plc.. In total, 9 reports have been published. Total volume traded: €349k. The latest transaction was filed on 23 February 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€261,84711,983 shares@ €21.85150.0057% mcap75.1% of flow
Ordinary Shares
SEC:0001127602-22-006622:0·
€51,0642,306 shares@ €22.14410.0011% mcap14.7% of flow
Ordinary Shares
SEC:0001127602-22-006332:0·
3,375 shares
Ordinary Shares
SEC:0001127602-22-005455:0·
015,143 shares0
Ordinary Shares
SEC:0001127602-21-025401·
015,143 shares0
Ordinary Shares
SEC:0001127602-21-025401:0·
€17,811882 shares@ €20.19370.0004% mcap5.1% of flow
Ordinary Shares
SEC:0001127602-21-019721:0·
€17,811882 shares@ €20.19370.0004% mcap100.0% of flow
Ordinary Shares
SEC:0001127602-21-019721·
1,250 shares
Ordinary Shares
SEC:0001127602-21-019458·
1,250 shares
Ordinary Shares
SEC:0001127602-21-019458:0·
9 of 9 declarations
About Hopkinson Craig C.
Craig C. Hopkinson is Senior Vice President R&D and Chief Medical Officer of Alkermes plc. He plays a key role in directing research and developing new treatments. His medical expertise is essential for the company's innovation.
